Herrmann Thomas, Thiede Grit, Trott Klaus-Rüdiger, Voigtmann Lutz
Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Dresden.
Strahlenther Onkol. 2004 Jan;180(1):21-30. doi: 10.1007/s00066-004-1223-4.
Many young adults with cancer of good prognosis seek advice from their doctors, because they are concerned about their ability to have children and about potential hereditary diseases in the children conceived or fathered after cancer therapy.
Results of repeated examinations of 61 children over a period of 20 years are reported. One of their parents had received radiotherapy for malignant disease (only three had additional chemotherapy). Radiation doses to the gonads ranged from 0.01 to 2 Gy. The most frequent indications for radiotherapy were Hodgkin's disease (n=25), seminomas (n=7), thyroid cancer (n=3), and malignant melanomas (n=3)
There was a trend to premature birth with 52.5% of the babies born before term. Yet, all had normal birth weight and delivery was inconspicuous. The skeletal maturation was retarded, but development was still in the normal range of German children. There were no chromosome aberrations, normal mental and intellectual development, and no malignancy among these children. A trend to an increased frequency of developmental disturbances and four moderately severe malformations were observed; however, no direct association with radiation treatment could be demonstrated. One child had a balanced translocation (5;17) which it inherited from the unirradiated parent.
During the first consultation of young adult cancer patients, before the start of treatment, the problems of fertility and of therapy-induced mutations and hereditary diseases as well as developmental damage of the offspring need to be addressed directly by the radiation oncologist. Decisions on cryoconservation of sperm, fixation of the ovaries and dosimetry of the gonads during radiotherapy have to be made before the start of treatment. The rate of radiation-induced hereditary diseases and developmental damage in the children conceived or fathered after curative radiotherapy of one parent is estimated to increase by <0.1% (after gonadal exposure of 1 Gy). However, at present, heritable damage potentially induced by chemotherapy cannot be adequately quantified yet.
许多预后良好的年轻癌症患者会向医生咨询,因为他们担心自己生育子女的能力以及癌症治疗后受孕或生育的子女可能患有的遗传性疾病。
报告了61名儿童在20年期间的多次检查结果。他们的父母中有一人曾接受过恶性疾病的放射治疗(只有三人接受了额外的化疗)。性腺的辐射剂量为0.01至2戈瑞。放射治疗最常见的适应症是霍奇金病(n = 25)、精原细胞瘤(n = 7)、甲状腺癌(n = 3)和恶性黑色素瘤(n = 3)。
早产趋势明显,52.5%的婴儿早产。然而,所有婴儿出生体重正常,分娩过程无异常。骨骼成熟延迟,但发育仍处于德国儿童的正常范围内。这些儿童中没有染色体畸变,智力和心理发育正常,也没有恶性肿瘤。观察到发育障碍频率增加的趋势以及四种中度严重的畸形;然而,无法证明与放射治疗有直接关联。一名儿童有平衡易位(5;17),这是从未接受辐射的父母那里遗传来的。
在年轻成年癌症患者首次咨询时,在治疗开始前,放射肿瘤学家需要直接解决生育问题、治疗引起的突变和遗传性疾病以及后代发育损伤等问题。在治疗开始前,必须就精子冷冻保存、卵巢固定和放射治疗期间性腺的剂量测定做出决定。估计一方接受根治性放射治疗后受孕或生育的子女中,辐射诱发的遗传性疾病和发育损伤的发生率增加<0.1%(性腺暴露1戈瑞后)。然而,目前化疗可能诱发的遗传损伤尚无法充分量化。